ArticleInflammopharmacology2019

IL-1β, IL-17A, CRP and biologics history might serve as potential markers for clinical response to etanercept in rheumatoid arthritis patients.

Bo Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.